Paul Tudor Jones Mirum Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

  • $26.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
BUY
$24.63 - $32.85 $176,523 - $235,435
7,167 Added 60.04%
19,104 $603,000
Q2 2023

Aug 14, 2023
BUY
$23.51 - $30.09 $280,638 - $359,184
11,937 New
11,937 $308,000
Q1 2021

May 17, 2021
SELL
$16.29 - $21.92 $407,250 - $548,000
-25,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.75 - $25.45 $393,750 - $636,250
25,000 New
25,000 $437,000

Others Institutions Holding MIRM

# of Institutions
190
Shares Held
54M
Call Options Held
177K
Put Options Held
167K
View Full List

About Mirum Pharmaceuticals, Inc.

MIRM Quotes by TradingView
  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.66B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email